Literature DB >> 8477976

Administration of prostaglandin E1 analog reduces rat hepatic and Ito cell collagen gene expression and collagen accumulation after bile duct ligation injury.

D W Beno1, R Espinal, B M Edelstein, B H Davis.   

Abstract

Recent studies suggest that prostaglandin E may have the ability to suppress cytokine responsiveness. We examined the effects of prostaglandin E administration on several parameters of acute and chronic liver injury induced by bile duct ligation. Enisoprost, a prostaglandin E1 analog, was found to suppress early hepatic and Ito cell type I collagen gene expression without diminishing the induction of the fibrogenic cytokine transforming growth factor-beta. Overall liver inflammation and cell proliferation were not altered, suggesting that prostaglandin E acts distal to the initial injurious event(s). During later phases, drug administration reduced total collagen accumulation and type I collagen periductular infiltration associated with early nodule formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477976     DOI: 10.1002/hep.1840170427

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

Review 1.  New strategies for treatment of pulmonary fibrosis.

Authors:  S H Phan
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

2.  Role of prostanoids and nitric oxide inhibition in rats with experimental hepatic fibrosis.

Authors:  M Criado; O Flores; M J Vázquez; A Esteller
Journal:  J Physiol Biochem       Date:  2000-09       Impact factor: 4.158

3.  Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis.

Authors:  X Bertrán; J Mañé; F Fernández-Bañares; E Castellá; R Bartolí; I Ojanguren; M Esteve; M A Gassull
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

4.  Prostaglandin E2 inhibits platelet-derived growth factor-stimulated cell proliferation through a prostaglandin E receptor EP2 subtype in rat hepatic stellate cells.

Authors:  Shigeki Koide; Yoshimasa Kobayashi; Yutaka Oki; Hirotoshi Nakamura
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

Review 5.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

6.  Retinoic acid suppresses the response to platelet-derived growth factor in human hepatic Ito-cell-like myofibroblasts: a post-receptor mechanism independent of raf/fos/jun/egr activation.

Authors:  B H Davis; D Coll; D W Beno
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

7.  An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver.

Authors:  R Mancini; A Benedetti; A M Jezequel
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.